Neumora Therapeutics, Inc. (NMRA)
1.875
-0.14
(-7.18%)
USD |
NASDAQ |
Jan 20, 16:00
1.875
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics EPS Diluted (Quarterly): -0.3507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ventyx Biosciences, Inc. | -0.3202 |
| Puma Biotechnology, Inc. | 0.1736 |
| Nautilus Biotechnology, Inc. | -0.1075 |
| ProKidney Corp. | -0.122 |
| MapLight Therapeutics, Inc. | -0.6484 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.76M |
| Total Expenses (Quarterly) | 56.76M |
| Enterprise Value | 186.08M |
| Earnings Yield | -78.04% |
| Normalized Earnings Yield | -76.89 |